GLP-1 Weight Loss Medications: Semaglutide vs Tirzepatide Explained
Unveiling the Paradigm Shift in Obesity Pharmacotherapy: The Rise of GLP-1 Receptor Agonists The clinical landscape for obesity management has profoundly evolved with the advent of glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide and tirzepatide, as leading pharmacological agents, exemplify this shift by leveraging incretin hormone pathways to achieve substantial weight reduction. This article dissects their … Read more